Co-Diagnostics, Inc. (CODX) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Co-Diagnostics, Inc. and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CODX
Co-Diagnostics, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
INM
InMed Pharmaceuticals Inc.
$1.34HealthcareDelayed quote: Oct 6, 2026, 9:47 AM EDT
Total return — CODX vs INM
growth of $100 · dividends reinvested · last 9yCODX -99.4% (-43.0%/yr)INM -100.0% (-59.1%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
CODX INM
CODX vs INM: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; INM's is the smaller (-0.61% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CODX | INM |
|---|---|---|
| P/S ratio | 9.53 | 0.00 |
| P/B ratio | 0.54 | 6.86 |
Profitability
| Metric | CODX | INM |
|---|---|---|
| Gross margin | 64.28% | 14.92% |
| Operating margin | -5025.53% | -0.52% |
| Net margin | -6523.04% | -0.61% |
| ROE | -370.16% | -1168.44% |
| ROIC | -219.15% | -995.44% |
Growth (annualized)
| Metric | CODX | INM |
|---|---|---|
| Revenue CAGR (5Y) | -62.43% | N/A |
| Total return CAGR (5Y) | -66.53% | -71.98% |
Frequently asked
- How have CODX and INM total returns compared?
- Over the past 5 years, CODX delivered -66.53% and INM delivered -71.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.